Author version of DOI: 10.1016/S2213-8587(19)30194-9 This page will display a link to the post-print author-version of the publication:

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
Thomas R Pieber, Bruce Bode, Ann Mertens, Young Min Cho, Erik Christiansen, Christin L Hertz, Signe O R Wallenstein, John B Buse, for the PIONEER 7 investigators
Lancet Diabetes Endocrinol 2019 S2213-8587(19)30194-9

Actual Serverdate: 19.07.2019

Click below for a free full text (authors post-print version):

Free full text - authors version

Thank you for your interest in this publication

For further information on the research topics of Pieber TR klick here